Jakob Kristian Holm Andersen

Jakob Kristian Holm Andersen

Auto-generated profile, based on publicly available information

Jakob Kristian Holm Andersen

The Maersk Mc‐Kinney Moeller Institute, SDU Robotics University of Southern Denmark Odense Denmark

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Ophthalmology Retina
Verified
Journal Article
Closed access
KNKatrine B. Nielsen
Katrine B. Nielsen
MLMie L. Lautrup
Mie L. Lautrup
JAJakob K.H. Andersen
Jakob K.H. Andersen
TSThiusius Rajeeth Savarimuthu
Thiusius Rajeeth Savarimuthu
JGJakob Grauslund
Jakob Grauslund

30 March 2019 in RMD Open
Verified
Journal Article
Open access
PDF file
JAJakob Kristian Holm Andersen
Jakob Kristian Holm Andersen
JPJannik Skyttegaard Pedersen
Jannik Skyttegaard Pedersen
MLMartin Sundahl Laursen
Martin Sundahl Laursen
KHKathrine Holtz
Kathrine Holtz
JGJakob Grauslund
Jakob Grauslund
SJSøren Andreas Just
Søren Andreas Just
Background The development of standardised methods for ultrasound (US) scanning and evaluation of synovitis activity by the OMERACT-EULAR Synovitis Scoring (OESS) system is a major step forward in the use of US in the diagnosis and monitoring of patients with inflammatory arthritis. The variation in interpretation of disease activity on US images can affect diagnosis, treatment and outcomes in clinical trials. We, therefore, set out to investigate if we could utilise neural network architecture for the interpretation of disease activity on Doppler US images, using the OESS scoring system. Methods Two state-of-the-art neural networks were used to extract information from 1342 Doppler US images from patients with rheumatoid arthritis (RA). One neural network divided images as either healthy (Doppler OESS score 0 or 1) or diseased (Doppler OESS score 2 or 3). The other to score images across all four of the OESS systems Doppler US scores (0–3). The neural networks were hereafter tested on a new set of RA Doppler US images (n=176). Agreement between rheumatologist’s scores and network scores was measured with the kappa statistic. Results For the neural network assessing healthy/diseased score, the highest accuracies compared with an expert rheumatologist were 86.4% and 86.9% with a sensitivity of 0.864 and 0.875 and specificity of 0.864 and 0.864, respectively. The other neural network developed to four class Doppler OESS scoring achieved an average per class accuracy of 75.0% and a quadratically weighted kappa score of 0.84. Conclusion This study is the first to show that neural network technology can be used in the scoring of disease activity on Doppler US images according to the OESS system.

1 September 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
ACAnders Bossel Holst Christensen
Anders Bossel Holst Christensen
SJSøren Andreas Just
Søren Andreas Just
JAJakob Kristian Holm Andersen
Jakob Kristian Holm Andersen
TSThiusius Rajeeth Savarimuthu
Thiusius Rajeeth Savarimuthu
Objectives We have previously shown that neural network technology can be used for scoring arthritis disease activity in ultrasound images from rheumatoid arthritis (RA) patients, giving scores according to the EULAR-OMERACT grading system. We have now further developed the architecture of this neural network and can here present a new idea applying cascaded convolutional neural network (CNN) design with even better results. We evaluate the generalisability of this method on unseen data, comparing the CNN with an expert rheumatologist. Methods The images were graded by an expert rheumatologist according to the EULAR-OMERACT synovitis scoring system. CNNs were systematically trained to find the best configuration. The algorithms were evaluated on a separate test data set and compared with the gradings of an expert rheumatologist on a per-joint basis using a Kappa statistic, and on a per-patient basis using a Wilcoxon signed-rank test. Results With 1678 images available for training and 322 images for testing the model, it achieved an overall four-class accuracy of 83.9%. On a per-patient level, there was no significant difference between the classifications of the model and of a human expert (p=0.85). Our original CNN had a four-class accuracy of 75.0%. Conclusions Using a new network architecture we have further enhanced the algorithm and have shown strong agreement with an expert rheumatologist on a per-joint basis and on a per-patient basis. This emphasises the potential of using CNNs with this architecture as a strong assistive tool for the objective assessment of disease activity of RA patients.

11 March 2022 in Acta Ophthalmologica
Verified
Journal Article
Open access
JAJakob Kristian Holm Andersen
Jakob Kristian Holm Andersen
MHMartin Slusarczyk Hubel
Martin Slusarczyk Hubel
TSThiusius Rajeeth Savarimuthu
Thiusius Rajeeth Savarimuthu
MRMalin Lundberg Rasmussen
Malin Lundberg Rasmussen
SSSimon Lyck Bjært Sørensen
Simon Lyck Bjært Sørensen
JGJakob Grauslund
Jakob Grauslund
Purpose: The incidence of diabetes continues to increase across the world. As the number of patients rises, so does the need for educated health care professionals. Diabetic retinopathy (DR) remains one of the primary complications in diabetes, and screening has proved to be a cost‐effective measure to avoid DR‐related blindness. Denmark has an established screening programme, but no formal training of the people responsible for analysing retinal images.Methods: We here present an online learning platform that offers a diabetic eye screening course for health care professionals undertaking screening responsibility in the Region of Southern Denmark. The course is divided into lectures, each focussed on identifying different levels of DR or detecting related lesions. The course is free to use on‐demand, contains instructional videos, interactive tests and exercises, and it is concluded with a certification test. The tools on the platform can in addition be used to generate data for research purposes, such as comparing users or experts in detection of lesions or annotating data for the development of machine learning models.Results: More than 150 participants have so far completed the course, and the platform is being adopted for education in other regions of Denmark.

19 October 2024 in Acta Ophthalmologica
Verified
Journal Article
Open access
DSDyllan Edson Similié
Dyllan Edson Similié
JAJakob K. H. Andersen
Jakob K. H. Andersen
SDSebastian Dinesen
Sebastian Dinesen
TSThiusius R. Savarimuthu
Thiusius R. Savarimuthu
JGJakob Grauslund
Jakob Grauslund
Purpose: To validate the performance of autonomous diabetic retinopathy (DR) grading by comparing a human grader and a self‐developed deep‐learning (DL) algorithm with gold‐standard evaluation.Methods: We included 500, 6‐field retinal images graded by an expert ophthalmologist (gold standard) according to the International Clinical Diabetic Retinopathy Disease Severity Scale as represented with DR levels 0–4 (97, 100, 100, 103, 100, respectively). Weighted kappa was calculated to measure the DR classification agreement for (1) a certified human grader without, and (2) with assistance from a DL algorithm and (3) the DL operating autonomously. Using any DR (level 0 vs. 1–4) as a cutoff, we calculated sensitivity, specificity, as well as positive and negative predictive values (PPV and NPV). Finally, we assessed lesion discrepancies between Model 3 and the gold standard.Results: As compared to the gold standard, weighted kappa for Models 1–3 was 0.88, 0.89 and 0.72, sensitivities were 95%, 94% and 78% and specificities were 82%, 84% and 81%. Extrapolating to a real‐world DR prevalence of 23.8%, the PPV were 63%, 64% and 57% and the NPV were 98%, 98% and 92%. Discrepancies between the gold standard and Model 3 were mainly incorrect detection of artefacts (n = 49), missed microaneurysms (n = 26) and inconsistencies between the segmentation and classification (n = 51).Conclusion: While the autonomous DL algorithm for DR classification only performed on par with a human grader for some measures in a high‐risk population, extrapolations to a real‐world population demonstrated an excellent 92% NPV, which could make it clinically feasible to use autonomously to identify non‐DR patients.

1 January 2018
Verified
Conference Paper
Closed access
JAJakob K H Andersen
Jakob K H Andersen
WJWilliam K Juel
William K Juel
JGJakob Grauslund
Jakob Grauslund
TSThiusius Rajeeth Savarimuthu
Thiusius Rajeeth Savarimuthu